Correction To: Persistent Mutant Oncogene Specific T Cells in Two Patients Benefitting From Anti-Pd-1

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-019-0547-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Improved Survival of CAR‐T and Tumor‐specific T Cells Caused by Anti‐PD‐1 scFv‐producing CAR‐T Cells

Cancer Science
Cancer ResearchMedicineOncology
2019English

Transduction of Human Dendritic Cells With Adenovirus Encoding Anti-Pd-1 Reduces PD-1 Expression on Co-Cultured T Cells

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells

Cancer Research
Cancer ResearchOncology
2015English

Imaging of Activated T Cells as an Early Predictor of Immune Response to Anti-Pd-1 Therapy

Cancer Research
Cancer ResearchOncology
2019English

Functional Differences Between PD-1+ and PD-1- CD4+ Effector T Cells in Healthy Donors and Patients With Glioblastoma Multiforme

PLoS ONE
Multidisciplinary
2017English

Vav1: An Oncogene That Regulates Specific Transcriptional Activation of T Cells

Blood
BiochemistryImmunologyCell BiologyHematology
2004English

Presence of Suppressor HIV-Specific CD8+ T Cells Is Associated With Increased PD-1 Expression on Effector CD8+ T Cells

Journal of Immunology
AllergyImmunology
2008English

CTLA4 Methylation Predicts Response to Anti–PD-1 and Anti–CTLA-4 Immunotherapy in Melanoma Patients

JCI insight
Medicine
2018English

Anti-Pd-1-Induced High-Grade Hepatitis Associated With Corticosteroid-Resistant T Cells: A Case Report

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy